Conversion from Twice-Daily to Once-Daily Tacrolimus Improves Graft Function but has no Influence on Proteinuria in Renal Transplant Recipients
Introduction. Tacrolimus extended-release formulation enables once-daily use. Although an increasing number of patients have been converted from twice-daily (Tac- BID) to once-daily (Tac-QD) formulation, the available information regarding the initiation and follow-up of Tac- QD is sparse. In the pr...
Main Authors: | Basic-Jukic Nikolina, Bubic-Filipi Ljubica, Katalinic Lea, Lelas Judita |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-12-01
|
Series: | BANTAO Journal |
Subjects: | |
Online Access: | https://doi.org/10.1515/bj-2016-0018 |
Similar Items
-
Efficacy and toxicity of once versus twice daily regimens of amikacin in febrile neutropenic pediatric cancer patients
by: Reda Abd-Elfattah, et al.
Published: (2017-03-01) -
Effects of Exenatide Twice Daily and Once Weekly on Weight Loss
by: Patel, Rajal, et al.
Published: (2013) -
A Meta-Analysis of the Efficacy and Toxicity of Twice-Daily vs. Once-Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer Based on Randomized Controlled Trials
by: Qian Wu, et al.
Published: (2020-01-01) -
Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients
by: Valeria Cademartori, et al.
Published: (2021-02-01) -
Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus
by: Gantar K, et al.
Published: (2020-09-01)